In this study, we combined the chemotherapeutic drug TMZ with RGD4C/AAVP‐Grp78‐mediated systemic gene therapy, delivered intravenously in mice, against intracranial human models of glioblastoma. Here, HSPA5 is linked to glioblastoma.